Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection (scientific article)

Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination

Q36559921

APOBEC-mediated viral restriction: not simply editing?

Q36736677

Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences

Q36845949

Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy

Q36854142

The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements

Q37096085

APOBEC proteins and intrinsic resistance to HIV-1 infection

Q37140468

A multi-site study using high-resolution HLA genotyping by next generation sequencing

Q38494977

Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication

Q39079333

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase

Q40899809

Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity

Q41900176

HIV-1 Vif adaptation to human APOBEC3H haplotypes

Q42261341

DNA deamination mediates innate immunity to retroviral infection

Q28179534

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

Q28210666

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

Q28275837

Not so different after all: a comparison of methods for detecting amino acid sites under selection

Q28306719

Viral population estimation using pyrosequencing

Q28472641

Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance

Q28475150

Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms

Q28541264

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

Q28578747

The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data

Q28742086

Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative

Q29547242

Datamonkey: rapid detection of selective pressure on individual sites of codon alignments

Q29615126

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

Q29618742

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

Q29618938

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Q29619510

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

Q29619994

Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities

Q31078477

Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis

Q33594457

The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells

Q33615181

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing

Q33680395

APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

Q33826968

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection

Q33828583

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells

Q33853620

Mutational and fitness landscapes of an RNA virus revealed through population sequencing

Q33953331

Genetic diversity of HIV-1: the moving target.

Q34087052

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

Q34092644

Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure

Q34120736

HIV-1 sequence variation: drift, shift, and attenuation

Q34175357

Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II.

Q34207464

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon

Q34211562

Cellular immune responses to HIV.

Q34223069

Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase

Q34239961

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

Q34242229

High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.

Q34582241

Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs

Q34671913

Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity

Q34742607

The molecular clock of HIV-1 unveiled through analysis of a known transmission history

Q35631348

P275

Creative Commons CC0 License

Q6938433

P6216

copyrighted, dedicated to the public domain by copyright holder

Q88088423

P433

issue

P304

page(s)

e1004281

P577

publication date

2014-07-31

P1433

published in

PLOS Pathogens

Q283209

P1476

title

Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection

P478

volume

Reverse relations

cites work (P2860)

Q37100587	A Canonical Correlation Analysis of AIDS Restriction Genes and Metabolic Pathways Identifies Purine Metabolism as a Key Cooperator
Q45324625	APOBEC Enzymes as Targets for Virus and Cancer Therapy.
Q47555165	APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
Q36263411	APOBEC3 Proteins in Viral Immunity.
Q37264399	APOBEC3 proteins can copackage and comutate HIV-1 genomes.
Q39111231	APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context
Q61449156	APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome
Q37512973	APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms
Q38394187	APOBECs and virus restriction
Q41059063	Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results
Q98159070	Association between APOBEC3s and HPV16 E2 gene hypermutation in Uygur females with cervical cancer
Q47380909	Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G.
Q59351211	Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
Q57484166	Estimating the mutational fitness effects distribution during early HIV infection
Q57295397	Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease
Q35834559	HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation
Q34473801	HIV-1 and interferons: who's interfering with whom?
Q46227536	Increasing the CpG dinucleotide abundance in the HIV-1 genomic RNA inhibits viral replication.
Q98665144	Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs
Q59351278	Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2'-Deoxyzebularine Analogues
Q35830651	Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms
Q30954229	Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.
Q38688274	Mechanisms of HIV-1 Control
Q36019742	Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation
Q36811895	Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels
Q36897321	Persistent HIV-1 replication maintains the tissue reservoir during therapy
Q93194984	Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies
Q49205554	Prediction of HIV-1 and HIV-2 proteins by using Chou's pseudo amino acid compositions and different classifiers.
Q47554842	Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region
Q58583800	RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids
Q38790689	Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides
Q35601655	Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo
Q33631993	Recent advances in understanding HIV evolution
Q38842472	Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
Q64109172	Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance
Q37207674	Role of the host restriction factor APOBEC3 on papillomavirus evolution
Q35068754	Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities
Q39011114	Sequence-Specific Sensing of Nucleic Acids
Q37629738	Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.
Q39065035	Viral reverse transcriptases.